FDA Process Pending
iNeuroskill is working to develop a surrogate biomarker for Parkinson's Disease. By measuring impairment in fine motor control using dynamic handwriting analysis, iNeuroskill can help physicians diagnose the early onset of PD as well as monitor the efficacy of treatment of each patient remotely via the Internet.